Towards universal access: Improving accessibility to high quality DOTs in Zimbabwe
What is the project about
This project seeks to reduce the burden of Tuberculosis by 2015 in line with the Millennium Development Goals and Stop TB Partnership targets.
UNDAF Outcome(s): Outcome 6.2: Improved access to (and uptake of) HIV treatment, care and support services.
Expected CP Outcome(s): Improved survival of TB and HIV co-infected patients through strengthening collaborative TB/HIV activities.
Expected Output(s): High quality Direct Observation Treatment Strategy (DOTS) expanded and strengthened and people with TB and communities empowered.
Who Finances it?
Major source of funds: The Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM)
Budget: Phase 1 USD 28,236,113, & Phase 2 USD 21,900,000.00
Phase 1: USD 22,402,007.00 i.e. 79%;
Phase 2: USD 11,077,097.00 i.e. 51% (as of June 2013) of the grant amounts for the phases
- Project Start Date
- (Phase 1) January 2010- December 2011, & (Phase 2) January 2012-December 2014
- Focal Point
- Verity Nyaga /Martim Maya
- Focus Area
- Ministry of Health and Child Care (National Tuberculosis Program), Health Services Board (HSB), and National Pharmaceutical Company of Zimbabwe (NatPharm); Population Service International (PSI); Southern Africa HIV and AIDS Dissemination Service (Safaids); City of Harare, City of Bulawayo, Rehabilitation and Prevention of Tuberculosis (RAPT), & Zimbabwe National Network of People Living with HIV (ZNNP+)